Pulse Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Pulse Biosciences

10/08/2021 24:42

* Pulse Biosciences Inc  PLSE.OQ  reported a quarterly adjusted
loss of 58 cents​​ per share for the quarter ended in June. The
mean expectation of three analysts for the quarter was for a
loss of 69 cents per share.
* Reported revenue was zero​;  analysts expected $34.00
thousand. 
* Pulse Biosciences Inc's reported EPS for the quarter was a
loss of 58 cents​.
* The mean earnings estimate of analysts had fallen by
about 38.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Pulse Biosciences Inc shares had risen by 39.6% this
quarter and lost 4.0% so far this year.
* The company reported a quarterly loss of $15.32 million.
* Wall Street's median 12-month price target for Pulse
Biosciences Inc is $40.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 9 at 11:41 p.m.  ​All
figures in US dollars unless otherwise stated